FDA Investigator Peter R Lenahan

Peter R Lenahan has inspections in 22 countries as of 13 Oct 2023. Peter R Lenahan has collaborated with a combinined 6625 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

370

Last Inspection Date:

13 Oct 2023

Investigator Role:

FDA Investigator

Redica ID:

100008619

Country:

United States of America, Colombia, Germany, Israel, Japan, Bulgaria, United Kingdom of Great Britain and Northern Ireland, Singapore, Italy, Argentina, Czechia, Russian Federation, Switzerland, Austria, Netherlands, Jordan, India, Spain, Turkey, Thailand, China, France

Co-Investigator(s):

Abthony C Warchut, Addam S Reynolds, Adetutu M Gidado, Alanna Lmussawwir Bias, Alberto A Viciedo, Ali A Patino, Allen Lou, Allison E Sincek, Amatul H Marium, Amy C Amaro, Amy L Singer, Amy M Codella, Amy M Cramer, Ana S Cabrera, Anastasia G Lolas, Anastasia I Offordile, Andrea Siegel, PhD, Andrew J Molesky, Andrew Saunders, Angela Mock, Ann Marie Montemurro, Anna Kevilag, Anna Kwilas, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Annette Melendez, Anthony C Warchut, Anthony J Donato, Anthony M Criscuolo, Jr, Anthony N Onianwa, Arduino Frankovic, Ashar P Parikh, Atul J Agrawal, Barbara A Gullick, Barbara D Wright, Barbara J Holladay, Barbara J Maulfair, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Bei Yu, Brandon C Heitmeier, Brandy D Brown, Brandy N Lepage, Byungja E Marciante, Byunja E Marciante, Camille D Brown, Cara M Minelli, Carl A Anderson, Cary Greene, CDR Ileana Barreto Pettit, Chaoying C Ma, Charles I Ann, Charles J Chacko, Charles M Edwards, Charles M Spyr, Cheryl A Grandinetti, Cheryl J Legrand, Christina N Maurino, Christina P Burkhart, Christine M Cerenzio, Christine M Smith, Christopher C Wilcox, Christopher Janik, Chunsheng Cai, PhD, Courtney N Long, Craig W Swanson, Cynthia A Harris, MD, RN, Cynthia E Bushee, Cynthia F Kleppinger, MD, Daniel J Grabicki, Daniel J Lahar, Daniel L Aisen, Darin S Wiegers, David H Smith, Dawn L Wydner, Deborah A Greco, Deborah B Nixon, Deborah M Mcgee, Delkis J Caycedo, Denise M Visco, Investigator, Dhaval H Patel, Diane C Thibodeau, Dien N Nguyen, Dipesh K Shah, Don A Leeseberg, Donald L Lech, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Douglas Florentino, Dr. Carmelo Rosa, Dr. Gopa Biswas, PhD, Dr. Zhou Chen (nmi), MD PhD, Dung N Tran, E Marciante, Edmund F Mrak, Jr, Edward J Janik, Elizabeth A Laudig, Emest F Bizjak, Emily A Walters, Emmanuel A Dimaano, Jr, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Francis J Eng, Frank J Marciniak, Frederick Razzaghi, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Gavin T Cua, Gene R Gunn, George Pyramides, Gerald Mierle, Gerald T O'connor, Gianine E Delade, Gianine E Tompkins, Guerlain Ulysse, Gunther Boekhoudt, PhD, Gwyn G Dickinson, Haley H Seymour, Hang N Guo, Hector J Colon Torres, Helen B Ricalde, Helen Verdel, Herrmann, Himanshu Gupta, PhD, Hugh M Mcclure, II, Israel Santiago, OCM, Jaclyn N Munsch, Jacob G Lutz, Jacqueline M Bowling, Jacqueline Mdiaz Albertini, James R Birkenstamm, James R Wormuth, Janet A Rajan, Janete F Guardia, Jean Blackston Hill, Jean M Kelahan, Jean M Mulinde, MD, Jeanne F Broderick, Jeffrey A Sincek, Jennifer C Adams, Jennifer Macmillan, Jessica S Estriplet, Joan A Loreng, Jocelyn T Ramos, Jogy George, John J Thibodeau, Jonah S Ufferfilge, Jonee J Mearns, Jorge E Martinez, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph H Procopio, Josh Renzon Ramilo, Joshua S Hoeh, Joy Rkozlowski Klena, Juanita P Versace, Julie D Bringger, Justine Tomasso, Karen E D'orazio, Kassa Ayalew, MD, Katherine E Jacobitz, Keith M Reilly, Kelli F Dobilas, Kenneth L Smalls, Kent A Conforti, Kent C Faul, Kerry A Kurdilla, Kevin D Kallander, Kim Lthomas Cruse, Kimberly A Coward, Kimberly L Schultz, King, Kinh Q Mac, Kinh Qouc Mac, Kip J Hanks, Kristy A Zielny, Krystal O Ogunremi, Laishan L Lam, Lata C Mathew, PhD, Laura E Garcia, Lauren Iacono Connors, PhD, Lauren L Vajo, Lawrence J Stringer, Lawrence R Johnson, LCDR Matthew J Morrison, LCDR Wilfred A Darang, Lenahan Lenahan, Peter R, Leonard Pesetsky, Li Li, Liatte Kreuger, PharmD, Liattle Krueger, Linda Thai, Lisa Harlan, Lisa Mathew, Logman A Mohamed, Loretta Nemchik, Lori A Holmquist, Lori J Silverstein, Lorraine L Chavis, Luella J Rossi, M Patriciaurphy Murphy, Maan S Abduldayem, Madushini Dharmasena, PhD, Makini Cobourne Duval, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia D Fields, Marea K Harmon, Margaret A Foster, Margaret M Annes, Margaret M Sands, Maria Estrella, Maricelys Mercado, Marie F Morin, Marjorie D Schultz, Mark R Mcclain, Mary P Murphy, Matthew A Spataro, Matthew C Watson, Matthew R Noonan, Maxwell Van Tassell, PhD, Maya M Davis, Mayar M Mussa, Melba T Rivera, Melba Trivera Clavell, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Miah Jung, Michael A Taylor, Michael C Ireland, Michael E Cimaglio, Michael F Skelly, PhD, Michael R Klapal, Michael Serrano, Michael Skelly, Michelle A Marsh, Michelle Hawkins, Michelle M Noe, Michelle M Parisi, Miguel G Manzano, Mike M Rashti, Minerva Rogers, Minh D Phan, Mohsen Rajabi Abhari, FDA, Mpris Inspector, Nancy A Bellamy, Nancy F Scheraga, Nancy L Rolli, Nealie C Newberger, Nerizza B Guerin, Nicholas A Violand, Nicola M Fenty Stewart, Nicole C Victoria, PhD, Niketa Patel, Nilufer Tampal, PhD, Nimmy Mathews, Nina Yang, Niraj Mehta, Normica G Facey, Omotunde O Osunsanmi, Patricia Fhughes Troost, Paul A Licata, Paul L Bellamy, Paul Mouris, Prabhu P Raju, Rabin N Ghoshal, Rachel T Evans, Rajiv R Srivastava, Ramesh Potla, PhD, Ramon A Hernandez, Rapti D Madurawe, Raymond Liu, Raymond T Oji, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Remache, Reyes Candau Chacon, PhD, Richard J Bashay, Richard W Berning, Rita F Larocca Mahoney, Robert C Coleman, Robert E Davis, Robert G Antonsen, Jr, Robert G Ruff, Robert J Doyle, Robert J Martin, Robert W Jennings, Rodney T Allnutt, Rterry Bolen, Ruben C Ayala, PharmD, Russell J Glapion, Ruth A Williams, Saleem A Akhtar, Sam H Haidar, PhD, Samantha J Pinizzotto, D V M, Sandra Kershaw, Sarah Adella Fave, Sarah L Clark, Schultz, Scott B Laufenberg, Scotty L Hargrave, Sharon K Gershon, Sharon K Thoma, PharmD, Sheri S Oliver, Sherri J Liu, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Sinai Davis, Sinai I Davis, Spiridoula Dimopoulos, Sripal R Mada, PhD, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Stephen R Souza, Steven P Donald, Susan M Halsted, Susan M Miller, Susanne M Richardson, MSc RAC ELS, Suzie L Kent, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Tawny L Colling, Thomas E Friel, Thomas J Arista, Thomas W Garvin, Thuy T Nguyen, LCDR, Toni S Sturgis, Tonia F Bernard, Toniette K Williams, Travis E Chapman, Tyanna N Hadley, Tynna N Hadley, Unnee Ranjan, Valerie C Reed, Valerie Reed, Victoria M Daddeo, Victoria Spivak, Wayne E Seifert, Wayne J Meyer, William J Leonard, William Leung, William R Chang, Willie Wilson, Willy A Orantes, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yangmin Ning, Yanming An, PhD, Yasamin Ameri, Yvesna C Blaise, Zachary A Bogorad, Zakaria I Ganiyu, Zhong Li, PhD

Peter R Lenahan's Documents

Publish Date	Document Type	Title
July, 2015	EIR	BioClinica Inc. - EIR, 2015-07-24
October, 2003	FDA 483 Response	Teva Pharmaceuticals USA, Inc. - Form 483R, 2003-10-16
April, 2003	FDA 483	Hoffmann La Roche Inc - Form 483, 2003-04-30
March, 2013	EIR	Bayer HealthCare Pharmaceuticals Inc. - EIR, 2013-03-28
June, 2018	FDA 483	Srivicha Krudsood, M.D., Ph.D. - Form 483, 2018-06-28
July, 2015	FDA 483 Response	BioClinica Inc. - Form 483R, 2015-07-24
February, 2018	FDA 483	Eisai, Inc. - Form 483, 2018-02-16
September, 2002	EIR	Blispak, Inc. - EIR, 2002-09-20
January, 2017	EIR	Novartis Pharmaceuticals Corporation - EIR, 2017-01-24
April, 2010	FDA 483	Novartis Pharmaceuticals Corporation - Form 483, 2010-04-20
May, 2012	EIR	Merck and Company - EIR, 2012-05-02
July, 2013	EIR	AMKS TIME RELEASE LAB, LLC - EIR, 2013-07-12
August, 2018	FDA 483	Immunomedics, Inc. - Form 483, 2018-08-01
May, 2011	FDA 483	Merck & Co., Inc. - Form 483, 2011-05-06
January, 2020	FDA 483	Mandeep S. Oberoi, M.D. - Form 483, 2020-01-10
July, 2012	FDA 483	Suporn Chuncharunee - Form 483, 2012-07-20
November, 2014	EIR	Forest Research Institute, Inc. - EIR, 2014-11-26
November, 2014	FDA 483	Forest Research Institute, Inc. - Form 483, 2014-11-26
September, 2006	EIR	SGS North America Inc. - EIR, 2006-09-05
April, 2005	FDA 483	Hoffmann La Roche Inc - Form 483, 2005-04-04
July, 2003	EIR	Forest Research Institute, Inc. - EIR, 2003-07-28
June, 2004	FDA 483	Novartis Pharmaceuticals Corporation - Form 483, 2004-06-10
December, 2015	FDA 483	Eisai, Inc. - Form 483, 2015-12-09
October, 2003	FDA 483	Teva Pharmaceuticals USA, Inc. - Form 483, 2003-10-02
May, 2018	FDA 483	E. Jeffrey Greenberg, MD - Form 483, 2018-05-30
November, 2014	FDA 483 Response	Forest Research Institute, Inc. - Form 483R, 2014-12-12
May, 2003	FDA 483	SGS North America Inc. - Form 483, 2003-05-28
January, 2007	FDA 483	Unit Dose Solutions, Inc. of New Jersey - Form 483, 2007-01-04
September, 2019	FDA 483 Response	Merck Sharp & Dohme LLC - Form 483R, 2019-09-24
December, 2015	EIR	Eisai, Inc. - EIR, 2015-12-09
October, 2003	FDA 483	Contract Coating Inc. - Form 483, 2003-10-10
April, 2003	EIR	Hoffmann La Roche Inc - EIR, 2003-04-30
August, 2018	EIR	Immunomedics, Inc. - EIR, 2018-08-01
May, 2013	EIR	Hoffmann La Roche Inc - EIR, 2013-05-09
March, 2009	FDA 483	Bayer HealthCare Pharmaceuticals Inc. - Form 483, 2009-03-31
July, 2013	FDA 483	AMKS TIME RELEASE LAB, LLC - Form 483, 2013-07-12
May, 2005	EIR	Aphena Pharma Solutions - New Jersey, LLC - EIR, 2005-05-26
December, 2015	FDA 483 Response	Eisai, Inc. - Form 483R, 2015-12-18
August, 2013	EIR	Merck Sharp & Dohme - EIR, 2013-08-16
December, 2003	EIR	Merck & Co., Inc. - EIR, 2003-12-05
September, 2017	EIR	Novartis Pharmaceuticals Corporation - EIR, 2017-09-07
August, 2009	FDA 483	Schering Corporation - Form 483, 2009-08-07
October, 2013	EIR	Merck Sharp & Dohme LLC - EIR, 2013-10-16
September, 2016	FDA 483	Allergan, PLC. - Form 483, 2016-09-01
September, 2019	EIR	Merck Sharp & Dohme LLC - EIR, 2019-09-06
February, 2012	FDA 483	Forest Research Institute, Inc. - Form 483, 2012-02-14
October, 2003	EIR	Contract Coating Inc. - EIR, 2003-10-10
November, 2018	EIR	Pfizer Laboratories Div Pfizer Inc - EIR, 2018-11-02
February, 2011	FDA 483	Novartis Pharmaceuticals Corporation - Form 483, 2011-02-25
October, 2003	FDA 483 Response	Contract Coating Inc. - Form 483R, 2004-01-02
March, 2003	EIR	Everest Life Sciences LLC - EIR, 2003-03-17
May, 2008	FDA 483	Schering Corporation - Form 483, 2008-05-05
May, 2008	FDA 483 Response	Schering Corporation - Form 483R, 2008-05-23
December, 2019	EIR	Boehringer Ingelheim Pharmaceuticals, Inc. - EIR, 2019-12-12
September, 2019	FDA 483	Merck Sharp & Dohme LLC - Form 483, 2019-09-06
September, 2007	FDA 483	Hoffmann La Roche Inc - Form 483, 2007-09-20
September, 2006	FDA 483	SGS North America Inc. - Form 483, 2006-09-05
March, 2013	FDA 483	Bayer HealthCare Pharmaceuticals Inc. - Form 483, 2013-03-28
January, 2021	EIR	Pfizer Inc. Groton Laboratories - EIR, 2021-01-08
October, 2003	EIR	Teva Pharmaceuticals USA, Inc. - EIR, 2003-10-02
October, 2018	EIR	Frontage Clinical Services Inc. - EIR, 2018-10-19
June, 2004	EIR	Novartis Pharmaceuticals Corporation - EIR, 2004-06-10
June, 2003	FDA 483	Inopak Ltd - Form 483, 2003-06-16
September, 2017	FDA 483	Labcorp Early Development Laboratories, Inc. - Form 483, 2017-09-27
October, 2013	FDA 483	Merck Sharp & Dohme LLC - Form 483, 2013-10-16
July, 2013	FDA 483 Response	AMKS TIME RELEASE LAB, LLC - Form 483R, 2013-07-30
August, 2005	EIR	Novartis Pharmaceuticals Corporation - EIR, 2005-08-11
September, 2017	EIR	Labcorp Early Development Laboratories, Inc. - EIR, 2017-09-27
August, 2018	FDA 483 Response	Immunomedics, Inc. - Form 483R, 2018-11-08
May, 2012	FDA 483	Merck and Company - Form 483, 2012-05-02
May, 2014	FDA 483	Frontage Clinical Services Inc. - Form 483, 2014-05-20
December, 2018	FDA 483 Response	Novartis Pharmaceuticals Corporation - Form 483R, 2019-01-21
January, 2017	FDA 483	Novartis Pharmaceuticals Corporation - Form 483, 2017-01-24
May, 2003	EIR	SGS North America Inc. - EIR, 2003-05-28
May, 2013	FDA 483	Hoffmann La Roche Inc - Form 483, 2013-05-09
April, 2005	EIR	Hoffmann La Roche Inc - EIR, 2005-04-04
December, 2019	FDA 483	Boehringer Ingelheim Pharmaceuticals, Inc. - Form 483, 2019-12-12
June, 2004	FDA 483 Response	Novartis Pharmaceuticals Corporation - Form 483R, 2004-07-02
June, 2003	EIR	Inopak Ltd - EIR, 2003-06-16
December, 2018	FDA 483	Novartis Pharmaceuticals Corporation - Form 483, 2018-12-14
March, 2017	EIR	Novartis Pharmaceuticals Corporation - EIR, 2017-03-02
January, 2019	FDA 483	Daiichi Sankyo, Inc. - Form 483, 2019-01-08
July, 2003	FDA 483	Forest Research Institute, Inc. - Form 483, 2003-07-28
February, 2004	FDA 483	Cordis Corporation - Form 483, 2004-03-03
April, 2003	FDA 483 Response	Hoffmann La Roche Inc - Form 483R, 2003-05-07
August, 2020	EIR	Labcorp Early Development Laboratories, Inc. - EIR, 2023-09-20
July, 2017	FDA 483	Teva API, Inc. - Form 483, 2017-07-18
May, 2019	FDA 483	Colgate-Palmolive Company - Form 483, 2019-07-25

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more